Shuai Liu

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

Shifu Xiao, Piu Chan, Tao Wang et al. · Alzheimer s Research & Therapy · 2021 · 202 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke

Jie Shuai, Zili Gong, Li Huang et al. · JAMA · 2022 · 202 citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Folic Acid Supplementation Mitigates Alzheimer’s Disease by Reducing Inflammation: A Randomized Controlled Trial

Hui Chen, Shuai Liu, Lü Ji et al. · Mediators of Inflammation · 2016 · 199 citations · Full text

Medicine, Neurology, Nutritional Sciences +17

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib

Guang Yang, Sara J. Buhrlage, Li Tan et al. · Blood · 2016 · 137 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +8

The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer

Wei Jiang, Tiancong He, Shuai Liu et al. · Journal of Hematology & Oncology · 2018 · 106 citations · Full text

Medicine, Cancer Biology, Oncology +17